Trial intelligence / Profile preview

Pecs II Block vs Surgeon Infiltration for Biceps Tenodesis

NCT04867369Phase 4Completed

Sponsor
NYU Langone Health
Start
Jul 2021
Primary completion
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by NYU Langone Health. Started Jul 2021; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04867369.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04867369.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call